ALB and glomerulosclerosis: More importantly, treatment of diabetic kidney disease in uninephrectomized db/db mice with a selective CTSS inhibitor (RO5461111) improved endothelial injury, albuminuria, and glomerulosclerosis as well as albumin leakage in the retina (Kumar Vr et al., 2016).